AtomVie inks strategic partnership with Jubilant Radiopharma to strengthen logistics and distribution in Clinical Trials

AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced ...

October 16, 2026 | Friday | News
World Health Expo to showcase trillion-dollar growth across pharma, biotech, longevity and wellness at 2027 edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000...

October 15, 2026 | Thursday | News
Japan's JCR Pharma receives marketing authorisation in Kuwait for Enzyme Replacement Therapy to treat Hunter Syndrome

Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...

October 15, 2026 | Thursday | News
Roche inks $1.06 B deal with China's Rona Therapeutics for RNA-based metabolic therapies

Chinese startup Rona Therapeutics has granted Roche an exclusive worldwide license for Rona's investigational RNAi candi...

October 14, 2026 | Wednesday | News
AI drug discovery must deliver repeatable value beyond hype: Insilico Medicine’s Feng Ren

Artificial intelligence is changing how researchers identify therapeutic targets and design molecules, but its lasting v...

October 13, 2026 | Tuesday | Opinion
ITOCHU Corp signs capital alliance agreement with MOLCURE Inc. for AI-based drug discovery in Japan

ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery t...

October 14, 2026 | Wednesday | News
Singapore's NTU and Boehringer Ingelheim collaborate to explore new approaches for treating obesity

Nanyang Technological University (NTU), Singapore and global biopharmaceutical company Boehringer Ingelheim will be...

October 13, 2026 | Tuesday | News
Australia's Firebrick Pharma secures $732k in strategic investments

Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through ...

October 12, 2026 | Monday | News
Ono Pharma inks $100 M agreement with Biohaven to develop and commercialise IgG degraders in Japan, South Korea, Taiwan, and ASEAN countries

Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...

October 12, 2026 | Monday | News
Foresee Pharma announces China NMPA approval of CAMCEVI® 42 mg for treatment of advanced prostate cancer

Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (G...

October 12, 2026 | Monday | News
Everest Medicines announces NMPA acceptance of LEROCHOL BLA for hypercholesterolemia

Everest Medicines announced on June 26, 2026, that China’s National Medical Products Administration (NMPA) accepte...

October 12, 2026 | Monday | News
Korea's LOTTE Biologics inks US-based manufacturing agreement with Alvotech to increase global supply

South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...

October 9, 2026 | Friday | News
Charles River and Autolomous launch Apollo Orchestrate for digital laboratory execution

Charles River Laboratories International, Inc. and Autolomous announced the launch of Apollo Orchestrate on October 6, 2...

October 8, 2026 | Thursday | News
GE HealthCare buys SOFIE Biosciences for $945 M to establish 'Final Mile' footprint for PET Radiopharmaceutical Supply in US

GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopha...

October 8, 2026 | Thursday | News
Andelyn Biosciences and PQP Group partner to streamline EU and UK supply pathways for cell and gene therapies

Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Developme...

October 8, 2026 | Thursday | News
Japan's Shionogi continues rare disease expansion with acquisition of IntraBio for $2 B

Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company develo...

October 8, 2026 | Thursday | News
AstraZeneca opens new global strategic R&D centre in Massachusetts, US

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kenda...

October 7, 2026 | Wednesday | News
Germfree launches biopharmaceutical isolator for cell and gene therapy workflows

Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences,...

October 6, 2026 | Tuesday | News
Merck inks up to $2.13 B oncology deal with China's SciBrunch

Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered...

October 6, 2026 | Tuesday | News
Novartis signs licensing deal worth $7.2 B with China's Abogen for mRNA therapies

China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered...

October 7, 2026 | Wednesday | News
Taiwan's Energenesis Biomedical joins hands with Korea-based Yoo Young Pharm to develop treatment for diabetic foot ulcers

Taiwan-based Energenesis Biomedical has signed a Memorandum of Understanding (MoU) with Yoo Young Pharm (YYO), a South K...

October 6, 2026 | Tuesday | News
Eli Lilly launches ‘Nujoom Al Ghad’ to build next generation of Emirati talent in healthcare

Eli Lilly and Company (Lilly Gulf) has announced the launch of Nujoom Al Ghad, a new graduate programme designed to deve...

October 5, 2026 | Monday | News
Australia's CSL inks $1.2 B deal with Swiss firm Alentis to develop lixudebart for rare kidney and liver diseases treatment

Australia-based CSL and Swiss firm Alentis Therapeutics have entered into an exclusive global collaboration agreement to...

October 5, 2026 | Monday | News
Bayer to invest $2.2 B in new manufacturing site in US to create highly-skilled jobs

Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, US. Bui...

October 3, 2026 | Saturday | News
High-salt diet may drive fatty liver disease differently in lean people: Duke-NUS pre-clinical study

Fatty liver disease is commonly associated with obesity, yet a growing number of people with normal body weight develop ...

October 1, 2026 | Thursday | News